Clinical Trial Details
| Trial ID: | L3010 |
| Source ID: | NCT05353686 |
| Associated Drug: | Placebo |
| Title: | A Trial Investigating the Effect of 4 Weeks Dosing of XEN-D0501 on Blood Glucose Reduction in Patients With Diabetes |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Efficacy|Safety|Pharmacokinetics|Diabetes Mellitus, Type 2 |
| Interventions: | DRUG: Placebo|DRUG: XEN-D0501 |
| Outcome Measures: | Primary: Primary endpoint, Fasting blood glucose after four weeks of bi-daily dosing of XEN-D0501, 4 weeks of treatment | |
| Sponsor/Collaborators: | Sponsor: Pila Pharma | Collaborators: Biomapas |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE2 |
| Enrollment: | 54 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT |
| Start Date: | 2019-02-25 |
| Completion Date: | 2019-12-19 |
| Results First Posted: | |
| Last Update Posted: | 2022-04-29 |
| Locations: | Kristavita, JSC, Jonava, LT-55201, Lithuania|"Auki sveikas" ("A klinika"), Kaunas, LT-44175, Lithuania|Saules seimos medicinos centras, JSC, Kaunas, LT-49449, Lithuania|Kaunas City Polyclinic / Dainava Outpatient Clinic, Kaunas, LT-51270, Lithuania|Kedainiai Hospital / Outpatient Department, Kedainiai, LT-57164, Lithuania|A. Navickas Outpatient Clinic, Klaipeda, LT-92304, Lithuania|Karoliniskiu Outpatient Clinic, Vilnius, LT-04318, Lithuania|Vilnius University Hospital Santaros Clinics / Family Center Department, Vilnius, LT-08661, Lithuania|Vilnius University Hospital Santaros Clinics, Vilnius, LT-08661, Lithuania|Vaidotas Urbanavicius Sole Proprietary Enterprise, Vilnius, LT-09112, Lithuania |
| URL: | https://clinicaltrials.gov/show/NCT05353686 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|